NASDAQ:LHCG

LHC Group - LHCG Stock Forecast, Price & News

$164.85

-0.04 (-0.02%)

(As of 10/6/2022 12:00 AM ET)

Add

Compare

Today's Range: $164.35
▼
$165.25
50-Day Range: $160.75
▼
$164.89
52-Week Range: $108.42
▼
$169.84

Volume: 205,486 shs
Average Volume: 424,093 shs
Market Capitalization: $5.12 billion

P/E Ratio: 69.56
Dividend Yield: N/A
Price Target: $167.00

LHC Group MarketRank™ Forecast

Analyst Rating: Hold
2.00 Rating Score
Upside/Downside: 1.3% Upside
$167.00 Price Target
Short Interest: Healthy
8.90% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.25
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 13.28%
From $4.97 to $5.63 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.61 out of 5 stars

Medical Sector

967th out of 1,075 stocks

Home Health Care Services Industry

8th out of 9 stocks

1.0

Analyst's Opinion

Consensus Rating
LHC Group has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 10 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $167.00, LHC Group has a forecasted upside of 1.3% from its current price of $164.85.
Amount of Analyst Coverage
LHC Group has received no research coverage in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
8.90% of the float of LHC Group has been sold short.
Short Interest Ratio / Days to Cover
LHC Group has a short interest ratio ("days to cover") of 9.5.
Change versus previous month
Short interest in LHC Group has recently decreased by 7.39%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
LHC Group does not currently pay a dividend.
Dividend Growth
LHC Group does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for LHCG.

1.8

News and Social Media Coverage

News Sentiment
LHC Group has a news sentiment score of 0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.42 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for LHC Group this week, compared to 1 article on an average week.
MarketBeat Follows
Only 2 people have added LHC Group to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, LHC Group insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 4.80% of the stock of LHC Group is held by insiders.
Percentage Held by Institutions
87.82% of the stock of LHC Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for LHC Group are expected to grow by 13.28% in the coming year, from $4.97 to $5.63 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of LHC Group is 69.56, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 124.98.
Price to Earnings Ratio vs. Sector
The P/E ratio of LHC Group is 69.56, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 123.64.
Price to Earnings Growth Ratio
LHC Group has a PEG Ratio of 4.60. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
LHC Group has a P/B Ratio of 3.16. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About LHC Group (NASDAQ:LHCG) Stock

LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. It operates through five segments: Home Health Services, Hospice Services, Home and Community-Based Services, Facility-Based Services, and Healthcare Innovations (HCI). The Home Health Services segment offers skilled nursing, medically oriented social services and physical, occupational, and speech therapy. The Hospice Services segment provides pain and symptom management accompanied by palliative medication, emotional and spiritual support, inpatient and respite care, homemaker services, dietary counseling, family bereavement counseling, and social worker visits. Its Home and Community-Based Services segment offers range of services, such as assistance with grooming, medication reminders, meal preparation, assistance with feeding, light housekeeping, respite care, transportation, and errand. The Facility-Based Services segment treats patients with severe medical conditions who require a high-level of care and frequent monitoring by physicians and other clinical personnel. This segment serves patients suffering from respiratory failure, neuromuscular and cardiac disorders, non-healing wounds, renal disorders, cancer, head and neck injuries, and mental disorders, as well as treats patients diagnosed with musculoskeletal impairments; and operates nursing facilities, family health center, rural health clinic, and physician practice, as well as offers physical therapy services. The HCI segment provides strategic health management services to accountable care organizations. As of December 31, 2021, it operated 557 home health services locations, 170 hospice locations, 136 community-based service locations, 11 long-term acute care hospitals with 12 locations, and 14 HCI locations. The company was founded in 1994 and is based in Lafayette, Louisiana.

Receive LHCG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LHC Group and its competitors with MarketBeat's FREE daily newsletter.

LHCG Stock News Headlines

October 3, 2022 | americanbankingnews.com

LHC Group, Inc. (NASDAQ:LHCG) Sees Significant Drop in Short Interest

August 11, 2022 | finance.yahoo.com

The 10 Stocks That Account for 90.88% of Varenne Capital’s 13F Portfolio

August 3, 2022 | finance.yahoo.com

LHC Group (LHCG) Lags Q2 Earnings and Revenue Estimates

August 3, 2022 | finance.yahoo.com

LHC Group announces second quarter 2022 financial results

July 15, 2022 | morningstar.com

LHC Group Inc - Stock News

July 13, 2022 | finance.yahoo.com

LHC Group to report second quarter 2022 earnings results on August 3, 2022

June 15, 2022 | nasdaq.com

LHC Group is Now Oversold (LHCG)

May 19, 2022 | msn.com

LHC Group's Return On Capital Employed Overview

May 13, 2022 | morningstar.com

SHAREHOLDER ALERT: Weiss Law Reminds LHCG, NLSN, GDNSF, and MSP Shareholders About Its Ongoing Investigations

May 5, 2022 | apnews.com

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CNR, Y, VEC, LHCG

May 5, 2022 | finance.yahoo.com

LHC Group (LHCG) Q1 Earnings Surpass Estimates

May 4, 2022 | investing.com

LHC Group Tops Q1 EPS by 4c

May 4, 2022 | finance.yahoo.com

LHC Group announces first quarter 2022 financial results

April 25, 2022 | finance.yahoo.com

LHC Group to report first quarter 2022 earnings results on May 4, 2022

April 19, 2022 | apnews.com

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates NLSN, TVTY, RNDB, LHCG

April 18, 2022 | markets.businessinsider.com

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates NLSN, LHCG, RNDB, SWM

April 13, 2022 | baystreet.ca

SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates LHCG, NLSN, MN, SAVE

April 11, 2022 | apnews.com

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates LHCG, NLSN, TVTY, TUFN

April 5, 2022 | apnews.com

SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates POLY, LHCG, NP, RNDB

March 30, 2022 | finance.yahoo.com

Company News for Mar 30, 2022

March 30, 2022 | finance.yahoo.com

LHC (LHCG) Moves 5.9% Higher: Will This Strength Last?

March 29, 2022 | benzinga.com

LHC GROUP ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of LHCG and Encourages Investors to Contact the Firm

March 29, 2022 | tmcnet.com

LHCG Stock Alert: Halper Sadeh LLP Announces Investigation Into Whether the Sale of LHC Group, Inc. Is Fair to Shareholders

March 29, 2022 | msn.com

Stocks making the biggest moves in the premarket: Nielsen Holdings, FedEx, LHC Group and more

March 29, 2022 | nasdaq.com

Optum And LHC Group To Combine

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive LHCG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LHC Group and its competitors with MarketBeat's FREE daily newsletter.

LHCG Company Calendar

Last Earnings: 8/03/2022
Today: 10/06/2022
Next Earnings (Estimated): 11/02/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Home health care services
Sub-Industry: Health Care Services
Sector: Medical
Current Symbol: NASDAQ:LHCG
CUSIP: 50187A10
CIK: 1303313
Web: www.lhcgroup.com
Phone: (337) 233-1307
Fax: 337-235-8037
Employees: 30,000
Year Founded: 1994

Price Target and Rating

Average Stock Price Forecast: $167.00
High Stock Price Forecast: $185.00
Low Stock Price Forecast: $150.00
Forecasted Upside/Downside: +1.3%
Consensus Rating: Hold
Rating Score (0-4): 2.00
Research Coverage: 10 Analysts

Profitability

EPS (Most Recent Fiscal Year): $2.37
Trailing P/E Ratio: 69.56
Forward P/E Ratio: 33.17
P/E Growth: 4.6
Net Income: $115.73 million
Net Margins: 3.20%
Pretax Margin: 5.24%
Return on Equity: 8.88%
Return on Assets: 5.16%

Debt

Debt-to-Equity Ratio: 0.46
Current Ratio: 1.37
Quick Ratio: 1.37

Sales & Book Value

Annual Sales: $2.22 billion
Price / Sales: 2.30
Cash Flow: $7.52 per share
Price / Cash Flow: 21.93
Book Value: $52.17 per share
Price / Book: 3.16

Miscellaneous

Outstanding Shares: 31,029,000
Free Float: 29,540,000
Market Cap: $5.12 billion
Optionable: Optionable
Beta: 0.46

Social Links

Key Executives

Mr. Keith G. Myers (Age 63)
Co-Founder, CEO & Chairman
Comp: $1M

Mr. Joshua L. Proffitt (Age 44)
Pres & Chief Operating Officer
Comp: $663k

Mr. Dale Gerard Mackel (Age 57)
Exec. VP, CFO & Treasurer
Comp: $505.24k

Mr. Nicholas Gachassin III (Age 55)
Exec. VP & Gen. Counsel
Comp: $418.46k

Mr. Bruce D. Greenstein B.S. (Age 53)
M.S., Exec. VP and Chief Strategy & Innovation Officer
Comp: $546.8k

Mr. John L. Indest (Age 70)
Consultant & Independent Director
Comp: $101.5k

Ms. Kimberly S. Seymour (Age 45)
Sr. VP & Chief Accounting Officer

Mr. Mohammad Ali
Chief Information Officer

Mr. Marcus D. Macip
Exec. VP & Chief Admin. Officer

Ms. JoAnne Little
Sr. VP & Chief Compliance Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

LHCG Stock - Frequently Asked Questions

Should I buy or sell LHC Group stock right now?: 10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for LHC Group in the last twelve months. There are currently 10 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" LHCG shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in LHCG, but not buy additional shares or sell existing shares.
View LHCG analyst ratings or view top-rated stocks.
What is LHC Group's stock price forecast for 2022?: 10 equities research analysts have issued 12 month target prices for LHC Group's stock. Their LHCG share price forecasts range from $150.00 to $185.00. On average, they predict the company's stock price to reach $167.00 in the next year. This suggests a possible upside of 1.3% from the stock's current price.
View analysts price targets for LHCG or view top-rated stocks among Wall Street analysts.
How have LHCG shares performed in 2022?: LHC Group's stock was trading at $137.23 at the beginning of 2022. Since then, LHCG stock has increased by 20.2% and is now trading at $164.93.
View the best growth stocks for 2022 here.
When is LHC Group's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 2nd 2022.
View our LHCG earnings forecast.
How were LHC Group's earnings last quarter?: LHC Group, Inc. (NASDAQ:LHCG) issued its quarterly earnings data on Wednesday, August, 3rd. The health services provider reported $0.98 earnings per share for the quarter, missing analysts' consensus estimates of $1.32 by $0.34. The health services provider earned $576.19 million during the quarter, compared to the consensus estimate of $598.94 million. LHC Group had a trailing twelve-month return on equity of 8.88% and a net margin of 3.20%.
What is Keith G. Myers' approval rating as LHC Group's CEO?: 524 employees have rated LHC Group Chief Executive Officer Keith G. Myers on Glassdoor.com. Keith G. Myers has an approval rating of 87% among the company's employees.

What other stocks do shareholders of LHC Group own?: Based on aggregate information from My MarketBeat watchlists, some companies that other LHC Group investors own include Verizon Communications (VZ), NVIDIA (NVDA), Home Depot (HD), Cisco Systems (CSCO), Visa (V), CVS Health (CVS), Johnson & Johnson (JNJ), Alibaba Group (BABA), Chevron (CVX) and Intel (INTC).
What is LHC Group's stock symbol?: LHC Group trades on the NASDAQ under the ticker symbol "LHCG."
Who are LHC Group's major shareholders?: LHC Group's stock is owned by a number of institutional and retail investors. Top institutional investors include American National Bank (0.00%). Insiders that own company stock include Nicholas Gachassin III, Ronald T Nixon and W Earl Reed III.
View institutional ownership trends.
How do I buy shares of LHC Group?: Shares of LHCG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is LHC Group's stock price today?: One share of LHCG stock can currently be purchased for approximately $164.93.
How much money does LHC Group make?: LHC Group (NASDAQ:LHCG) has a market capitalization of $5.12 billion and generates $2.22 billion in revenue each year. The health services provider earns $115.73 million in net income (profit) each year or $2.37 on an earnings per share basis.
How many employees does LHC Group have?: The company employs 30,000 workers across the globe.
How can I contact LHC Group?: LHC Group's mailing address is 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA, 70508. The official website for the company is www.lhcgroup.com. The health services provider can be reached via phone at (337) 233-1307, via email at eric.elliott@lhcgroup.com, or via fax at 337-235-8037.

This page (NASDAQ:LHCG) was last updated on 10/7/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

LHC Group - LHCG Stock Forecast, Price & News

LHC Group MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month